1.Name of Company:INTERNATIONAL BIOTECHNOLOGY TRUST PLC
2.Name of scheme:GENERAL CORPORATE PURPOSES SCHEME
3.Period of return:FROM 9 JANUARY 2008 to 9 JULY 2008
4.Number and class of share(s) not issued under scheme:791,067 ORDINARY SHARES
5.Number of shares issued/allotted under scheme during the period:NIL
6.Balance under scheme not yet issued/allotted at end of period:791,067 ORDINARY SHARES
7. Number and class of shares(s) (amount of stock/debt securities) originally listed and the date of admission: 1,741,067 – ADMITTED TO LISTING ON 9 JULY 2007
Please confirm the total number of shares in issue at the end of the period in order for us to update our records: 70,592,664 ORDINARY SHARES OF 25 PENCE EACH
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.